Boston Scientific Corporation (BSX) 재무상태표
NYSE · Healthcare · Medical - Devices · 직원 59,000명 · CEO Michael F. Mahoney
- 주가
- $41.98 -1.66%
- 시가총액
- $608억
- 기업가치
- $729억
- 최근 실적
- Q3 '26 2026-09-30 제출
- 다음 실적
- 2027-02-03 EPS 추정 $0.79
Boston Scientific Corporation (BSX)의 Q2 '26말 현금 및 단기투자는 $5.39억, 리스 포함 차입금은 $126억입니다. 자산총계 $452억, 부채총계 $200억, 주주지분 $249억.
재무상태표
| 재무상태표 | 추세 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $9.52억 | $8.65억 | $23.3억 | $29.1억 | $25억 | $4.14억 | $7.25억 | $5.34억 | $12.8억 | $20.5억 | $15.2억 | $5.39억 | |
| 매출채권 | $21억 | $22.3억 | $23억 | $24억 | $25억 | $25.6억 | $26.9억 | $28.2억 | $28.3억 | $29.3억 | $30.3억 | $30.5억 | |
| 재고자산 | $24억 | $24.8억 | $25.6억 | $26.1억 | $27.5억 | $28.1억 | $28.7억 | $28.6억 | $29.2억 | $29.4억 | $31.2억 | $32.4억 | |
| 기타 유동자산 | $7.4억 | $6.22억 | $6.72억 | $7.55억 | $6.73억 | $8.31억 | $7.56억 | $6.13억 | $7.01억 | $5.8억 | $6.58억 | $7.6억 | |
| 유동자산 | $65억 | $65.1억 | $81.9억 | $89.9억 | $87.6억 | $69.2억 | $73.4억 | $71.2억 | $80.4억 | $87.9억 | $86.8억 | $79.7억 | |
| 유형자산(순액) | $30.8억 | $33억 | $33.3억 | $33.7억 | $35억 | $37.4억 | $38.4억 | $39.5억 | $42.9억 | $45억 | $46.1억 | $41.3억 | |
| 장기투자 | $4.27억 | $4.13억 | $4.29억 | $5.89억 | $5.32억 | $5.55억 | $6.55억 | $6.26억 | $7.92억 | $8.42억 | $9.35억 | $22.5억 | |
| 영업권 | $136억 | $144억 | $144억 | $144억 | $150억 | $171억 | $173억 | $181억 | $182억 | $183억 | $185억 | $186억 | |
| 무형자산 | $58.5억 | $60억 | $58.4억 | $54.2억 | $57.5억 | $66.8억 | $65.7억 | $72.6억 | $71.6억 | $70.2억 | $70.6억 | $69.2억 | |
| 이연법인세자산 | $38.4억 | $38.4억 | $37.9억 | $38억 | $38.2억 | $36.6억 | $36.8억 | $37.8억 | $36.7억 | $36.8억 | $39.5억 | $39.1억 | |
| 기타 비유동자산 | $7.32억 | $6.79억 | $7.37억 | $5.46억 | $6.84억 | $7.49억 | $7.32억 | $7.46억 | $5.46억 | $5.59억 | $5.73억 | $14.1억 | |
| 비유동자산 | $275억 | $286억 | $285억 | $281억 | $293억 | $325억 | $328억 | $344억 | $347억 | $349억 | $357억 | $372억 | |
| 자산총계 | $340억 | $351억 | $367억 | $371억 | $381억 | $394억 | $401억 | $416억 | $427억 | $437억 | $444억 | $452억 | |
| 부채 | |||||||||||||
| 매입채무 | $9.29억 | $9.42억 | $9.21억 | $9.06억 | $9.07억 | $9.6억 | $10억 | $9.62억 | $10억 | $11.4억 | $11.4억 | $12.3억 | |
| 미지급비용 | $9.12억 | $10.5억 | $7.49억 | $9.48억 | $11.1억 | $26억 | $22.2억 | $26.7억 | $28.3억 | $14.3억 | $0 | $27.6억 | |
| 단기차입금 | $5.13억 | $5.31억 | $10.9억 | $15.8억 | $16.5억 | $17.8억 | $7.77억 | $4.8억 | $4.83억 | $3.89억 | $4100만 | $17.1억 | |
| 미지급세금 | $3.52억 | $2.2억 | $2.57억 | $2.24억 | $3.32억 | $2.68억 | $2.94억 | $1.73억 | $1.74억 | $2.99억 | $0 | $3.9억 | |
| 이연수익 | $2.46억 | $2.66억 | $2.8억 | $2.84억 | $2.9억 | $3.06억 | $3.06억 | $3.13억 | $3.09억 | $3.13억 | $0 | $0 | |
| 기타 유동부채 | $16.3억 | $19.2억 | $16.2억 | $16.3억 | $16.6억 | $4.91억 | $4.39억 | $5.97억 | $5.31억 | $21.7억 | $33.9억 | $7.32억 | |
| 유동부채 | $45.8억 | $49.3억 | $49.2억 | $55.8억 | $59.1억 | $64억 | $50.6억 | $51.9억 | $53.3억 | $54.4억 | $45.7억 | $64.3억 | |
| 장기차입금 | $83.8억 | $85.7억 | $95.3억 | $89.9억 | $92.3억 | $88.4억 | $104억 | $110억 | $110억 | $115억 | $109억 | $108억 | |
| 리스부채(비유동) | $4.04억 | $3.95억 | $3.86억 | $3.69억 | $3.77억 | $5.27억 | $5.25억 | $5.66억 | $5.7억 | $5.71억 | $1.24억 | $1.24억 | |
| 이연수익(비유동) | $3.01억 | $3.11억 | $3.14억 | $3.16억 | $3.28억 | $3.29억 | $3.35억 | $3.49억 | $3.59억 | $3.69억 | $0 | $0 | |
| 이연법인세부채 | $9100만 | $1.34억 | $1.32억 | $1.32억 | $1.38억 | $1.55억 | $1.58억 | $2.26억 | $2.42억 | $2.2억 | $2.19억 | $2.21억 | |
| 기타 비유동부채 | $11.6억 | $12.7억 | $12.2억 | $11.2억 | $11.4억 | $11.4억 | $12.1억 | $15.9억 | $15.9억 | $11.4억 | $24.7억 | $24.8억 | |
| 비유동부채 | $103억 | $107억 | $116억 | $109억 | $112억 | $110억 | $126억 | $137억 | $137억 | $138억 | $137억 | $136억 | |
| 부채총계 | $149억 | $156억 | $165억 | $165억 | $171억 | $174억 | $177억 | $189억 | $191억 | $192억 | $182억 | $200억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | |
| 이익잉여금 | $3.15억 | $8.19억 | $13.1억 | $16.4억 | $21.1억 | $26.7억 | $33.5억 | $41.4억 | $49억 | $55.7억 | $69.1억 | $78.2억 | |
| 기타포괄손익누계액 | $2.31억 | $4900만 | $1.33억 | $1.64억 | -$1.28억 | $2.75억 | -$2800만 | -$7.22억 | -$6.89억 | -$6.1억 | -$3.98억 | -$3.04억 | |
| 주주지분 | $189억 | $193억 | $199억 | $204억 | $207억 | $218억 | $222억 | $224억 | $234억 | $242억 | $259억 | $249억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $93억 | $94.9억 | $110억 | $109억 | $113억 | $111억 | $117억 | $120억 | $120억 | $124억 | $110억 | $126억 | |
| 순차입금(차입금 - 현금) | $83.5억 | $86.3억 | $86.7억 | $80.2억 | $87.6억 | $107억 | $110억 | $115억 | $108억 | $104억 | $95.1억 | $121억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $1.96억 | $1.88억 | $1.46억 | $2.17억 | $17.3억 | $19.3억 | $9.28억 | $8.65억 | $4.14억 | $20.5억 | |
| 매출채권 | $14.7억 | $15.5억 | $16.1억 | $18.3억 | $15.3억 | $17.8억 | $19.7억 | $22.3억 | $25.6억 | $29.3억 | |
| 재고자산 | $9.55억 | $10.8억 | $11.7억 | $15.8억 | $13.5억 | $16.1억 | $18.7억 | $24.8억 | $28.1억 | $29.4억 | |
| 기타 유동자산 | $5.41억 | $9.42억 | $9.22억 | $8.8억 | $18.8억 | $7.99억 | $7.31억 | $6.22억 | $8.31억 | $5.8억 | |
| 유동자산 | $32.4억 | $38.2억 | $40억 | $47억 | $66.9억 | $63.2억 | $57.6억 | $65.1억 | $69.2억 | $87.9억 | |
| 유형자산(순액) | $16.3억 | $17억 | $17.8억 | $24.2억 | $25.4억 | $26.9억 | $28.3억 | $33억 | $37.4억 | $45억 | |
| 장기투자 | -$7500만 | -$1.91억 | -$3.28억 | $4.58억 | $9.18억 | $4.12억 | $4.07억 | $4.13억 | $5.55억 | $8.42억 | |
| 영업권 | $66.8억 | $70억 | $79.1억 | $102억 | $99.5억 | $120억 | $129억 | $144억 | $171억 | $183억 | |
| 무형자산 | $58.8억 | $58.4억 | $63.7억 | $78.9억 | $59.2억 | $61.2억 | $59억 | $60억 | $66.8억 | $70.2억 | |
| 이연법인세자산 | $7500만 | $1.91억 | $3.28억 | $42억 | $42.1억 | $41.4억 | $39.4억 | $38.4억 | $36.6억 | $36.8억 | |
| 기타 비유동자산 | $6.66억 | $6.88억 | $9.32억 | $7.35억 | $5.45억 | $5.63억 | $7.07억 | $6.8억 | $7.49억 | $5.59억 | |
| 비유동자산 | $149억 | $152억 | $170억 | $259억 | $241억 | $259억 | $267억 | $286억 | $325억 | $349억 | |
| 자산총계 | $181억 | $190억 | $210억 | $306억 | $308억 | $322억 | $325억 | $351억 | $394억 | $437억 | |
| 부채 | |||||||||||
| 매입채무 | $4.47억 | $5.3억 | $3.49억 | $5.42억 | $5.13억 | $7.94억 | $8.62억 | $9.42억 | $9.6억 | $11.4억 | |
| 미지급비용 | $5.72억 | $5.91억 | $6.3억 | $16.4억 | $16.9억 | $21.7억 | $8.3억 | $10.5억 | $26억 | $14.3억 | |
| 단기차입금 | $6400만 | $18억 | $22.5억 | $14.2억 | $1300만 | $2.61억 | $2000만 | $5.31억 | $17.8억 | $3.89억 | |
| 미지급세금 | $0 | $6600만 | $1.61억 | $2.65억 | $1.58억 | $2.09억 | $2.32억 | $2.2억 | $3.07억 | $2.99억 | |
| 이연수익 | $7500만 | $1.91억 | $3.28억 | $1.44억 | $1.38억 | $2.08억 | $2.2억 | $2.66억 | $3.06억 | $3.13억 | |
| 기타 유동부채 | $25억 | $27.3억 | $20.3억 | $8.61억 | $11.7억 | $6.29억 | $16.4억 | $19.2억 | $4.91억 | $21.7억 | |
| 유동부채 | $35.9억 | $56.5억 | $52.6억 | $48.7억 | $36.8억 | $42.7억 | $38억 | $49.3억 | $64억 | $54.4억 | |
| 장기차입금 | $54.2억 | $38.2억 | $48억 | $85.9억 | $91.2억 | $88억 | $89.1억 | $85.7억 | $88.4억 | $115억 | |
| 리스부채(비유동) | $100만 | $100만 | $0 | $2.82억 | $4.08억 | $3.95억 | $3.52억 | $3.95억 | $5.27억 | $5.71억 | |
| 이연수익(비유동) | $0 | $18.8억 | $11.9억 | $0 | $2.57억 | $2.76억 | $2.89억 | $3.11억 | $3.29억 | $3.69억 | |
| 이연법인세부채 | $1800만 | $1.91억 | $3.28억 | $5.95억 | $3.3억 | $3.1억 | $1.44억 | $1.34억 | $1.55억 | $2.2억 | |
| 기타 비유동부채 | $23.4억 | $23.7억 | $18.8억 | $23.6억 | $16.6억 | $15.5억 | $14억 | $12.7억 | $11.4억 | $11.4억 | |
| 비유동부채 | $77.8억 | $63.8억 | $70.1억 | $118억 | $118억 | $113억 | $111억 | $107억 | $110억 | $138억 | |
| 부채총계 | $114억 | $120억 | $123억 | $167억 | $155억 | $156억 | $149억 | $156억 | $174억 | $192억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $1900만 | $1600만 | $1600만 | $1600만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | $1700만 | |
| 이익잉여금 | -$85.8억 | -$83.9억 | -$69.5억 | -$22.5억 | -$23.8억 | -$13.9억 | -$7.5억 | $8.19억 | $26.7억 | $55.7억 | |
| 기타포괄손익누계액 | $100만 | -$5900만 | $3300만 | $2.7억 | $2.07억 | $2.63억 | $2.69억 | $4900만 | $2.75억 | -$6.1억 | |
| 주주지분 | $67.3억 | $70.1억 | $87.3억 | $139억 | $153억 | $166억 | $176억 | $193억 | $218억 | $242억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $54.8억 | $55.8억 | $70.3억 | $103억 | $95.4억 | $94.5억 | $92.8억 | $94.9억 | $111억 | $124억 | |
| 순차입금(차입금 - 현금) | $52.9억 | $53.9억 | $68.8억 | $101억 | $78.1억 | $75.3억 | $83.5억 | $86.3억 | $107억 | $104억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
데이터 기준일 2026-11-01